Joint Venture Between Teva And Korea’s Handok Appears Imminent
This article was originally published in PharmAsia News
Executive Summary
Similar to its approach in Japan in 2007, Teva appears to be trying to enter Korea through a joint venture, and not an outright acquisition. Handok, for its part, is preparing to expand beyond pharmaceuticals to devices and nutritional supplements.